Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8754114 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

Patent 8754114 was granted and assigned to Incyte on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87541140

Patent Inventor Names

Colin Zhang0

Chunhong He0

Jincong Zhuo0

Meizhong Xu0

Wenqing Yao0

Date of Patent

June 17, 2014

Patent Application Number

133330210

Date Filed

December 21, 2011

Patent Citations Received

‌

US Patent 12024517 Salts of an FGFR inhibitor

‌

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

‌

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

‌

US Patent 11667635 Bicyclic heterocycles as FGFR4 inhibitors

‌

US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors

‌

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

‌

US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors

‌

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

Patent Primary Examiner

‌

Paul V Ward

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8754114 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API